• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about NanoViricides

Recent news which mentions NanoViricides

A New COVID-19 Variant Is Rapidly Spreading Around The Globe, Other Pandemic Threats Exist – What Are The Choices For Treatment?
January 31, 2024
Tickers GILD NNVC PFE
Tags NNVC Partner Content Market News
From Benzinga
NanoViricides, Inc. (NNVC) To Unveil Cutting-Edge Antiviral Breakthroughs At Biotech Showcase™ 2024
January 08, 2024
Tickers NNVC
Tags NNVC Penny Stocks NanoViricides
From Benzinga
As 2023 Comes To A Close And Updates Are Expected From Many Companies, Are These Three Unique Biotech Names On Your Watchlist?
December 18, 2023
Tickers DNA LLY NVO PFE
Tags DNA PFE NVO
From Benzinga
Is This Ticker That InvestorObservers Expects To Soar By More Than 350% Next Year On Your Watchlist?
November 30, 2023
Tags Partner Content NanoViricides General
From Benzinga
NanoViricides updates progress on Phase 1a/1b clinical trial of antiviral drug candidate NV-387
November 29, 2023
Tags XNYS:NNVC NanoViricides
From TheNewswire.com - RSS (Media)
Multi-Billion Dollar Treatment Market For Lung Infection That Causes Over 200,000 Hospitalizations Annually With Elderly, Young At Most Risk Has Game-Changing New Entrant
October 02, 2023
Tickers AZN GSK NNVC PFE
Tags General Biotech SNY
From Benzinga
Multi-Billion Dollar Treatment Market For Lung Infection That Causes Over 200,000 Hospitalizations Annually With Elderly, Young At Most Risk Has Game-Changing New Entrant
September 26, 2023
Tickers AZN GSK NNVC PFE
Tags NNVC NanoViricides Benzinga
From Benzinga
First Human Clinical Trials Of A Potentially "Game-Changing Broad Spectrum Antiviral" Are Progressing Successfully – Drug Could Treat COVID, RSV And Many Other Respiratory Viruses
September 18, 2023
Tickers PFE
Tags PFE Partner Content NanoViricides
From Benzinga
NanoViricides progressing well with new Covid study
August 31, 2023
Tags NanoViricides XNYS:NNVC
From TheNewswire.com - RSS (Media)
SARS-CoV-2 Is Not Done Yet — Could This New Drug In Clinical Trials Be The Safest Option For Treating COVID-19?
July 18, 2023
Tickers GILD MRK NNVC PFE
Tags NanoViricides General Benzinga
From Benzinga
NanoViricides testing oral gummy and syrup Covid-19 treatment - Proactive Research Analyst
July 13, 2023
Tags XNYS:NNVC NanoViricides
From TheNewswire.com - RSS (Media)
NanoViricides Inc. (NYSE American: NNVC) Begins Long-Awaited Clinical Trials For Its Anti-Viral Nanomedicine NV-CoV-2, Oral, Amid Continuing Need For COVID Treatment
July 05, 2023
Tickers GILD MRK NNVC PFE
Tags Partner Content NNVC Penny Stocks
From Benzinga
NanoViricides take big step forward beginning trials on its antiviral drug NV-CoV-2
June 29, 2023
Tags NanoViricides XNYS:NNVC
From TheNewswire.com - RSS (Media)
This Biotech's Stock Has Been Under Pressure, Could Upcoming Clinical Trials Of Its Nanotechnology-Based COVID Drug Candidate Be The Start Of An Upward March?
April 19, 2023
Tickers SGEN SGMO SRPT
Tags SGEN NanoViricides Benzinga
From Benzinga
NanoViricides using unique technology platform to fight against viruses
April 12, 2023
Tags NanoViricides XNYS:NNVC
From TheNewswire.com - RSS (Media)
COVID Remains A Global Threat – NanoViricides Set To Begin Clinical Trials For Pan-Coronavirus Drug To Help Defeat COVID Once And For All
March 31, 2023
Tickers AZN GILD MRK MRNA
Tags NVAX GILD MRK
From Benzinga
A Company With Solutions Against Emerging COVID Variants And Other Viral Infections To Combat Future Pandemic Threats
March 20, 2023
Tickers GILD MRK MRNA NVAX
Tags PFE GILD MRK
From Benzinga
With Nearly 20,000 Americans Still Hospitalized, COVID Remains A Threat – NanoViricides Gets Ready To Begin Clinical Trials For The World To Defeat It, And To Prepare For Battling Against The Next Lik
March 08, 2023
Tickers NNVC
Tags Partner Content NNVC Penny Stocks
From Benzinga
This Company Is Looking For A Monkeypox Drug As City Investigates Deaths
October 27, 2022
Tickers NNVC
Tags Penny Stocks Partner Content NNVC
From Benzinga
European Patent Office Issues Intent To Grant Longeveron Patent Related To Methods To Monitor Efficacy Of Lomecel-B™ Cell Therapy
August 26, 2022
Tickers LGVN
Tags LGVN News Partner Content
From Benzinga
European Patent Office Issues Intent To Grant Longeveron Patent Related To Methods to Monitor Efficacy of Lomecel-B™ Cell Therapy
August 26, 2022
Tickers LGVN
Tags Market News General Benzinga
From Benzinga
Omicron BA.4/5 Subvariants Are More Contagious And More Treatment-Resistant, But This Biopharma Reports Working On A Potential Breakthrough
August 03, 2022
Tickers LLY PFE
Tags PFE Markets News
From Benzinga
NanoViricides Patents Its Antiviral Nanotechnology for COVID-19, Continuing Its Development of Potentially Broad-Spectrum Drugs That Are Expected To Be Effective Even Against Emerging Variants
May 25, 2022
Tickers MRNA NNVC PFE
Tags Penny Stocks MRNA NNVC
From Benzinga
NanoViricides Begins Drug Development Against Severe Pediatric Hepatitis; Expects To Be Successful In Short Period If Existing Candidates In Drug Library Prove Effective
May 18, 2022
Tags NanoViricides Market News Biotech
From Benzinga
NanoViricides Reports That It Has Begun Drug Development To Combat Recent Cases Of Severe Pediatric Hepatitis
May 16, 2022
Tags Partner Content NanoViricides Press Releases
From Benzinga
Does the FDA Rollback Of Regeneron And Eli Lilly COVID Treatment EUAs Signal A Need To Look Beyond Monoclonal Antibodies? NanoViricides, Inc. Looks To Meet This Need With A New Approach
February 28, 2022
Tickers GSK LLY NNVC REGN
Tags GSK Penny Stocks Partner Content
From Benzinga
Booster Shots Might Not Be Enough to Beat Omicron, According to Some Nanotech Experts
January 19, 2022
Tickers BNTX NNVC PFE
Tags Penny Stocks NNVC Partner Content
From Benzinga
NanoViricides Says Data Shows Its New Antiviral Could Fight all COVID-19 Variants
December 22, 2021
Tickers MRK PFE
Tags MRK Health Care PFE
From Benzinga
NanoViricides Attempts to Leverage Decades of Combined Pharmaceutical and Biotech Experience To Bring Broad-Spectrum COVID-19 Antiviral to Market
December 20, 2021
Tickers MRNA NNVC PFE
Tags Partner Content NNVC MRNA
From Benzinga
NanoViricides Says Its Nanomedicine Tech Could Be the Key To Defeating Omicron and Other COVID-19 Variants
December 09, 2021
Tickers JNJ MRNA NNVC PFE
Tags PFE JNJ Market News
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap